Skip to main content
Premium Trial:

Request an Annual Quote

Novartis Genomics Institute to Develop Assays with Q3DM

NEW YORK, Dec. 13 — Q3DM will collaborate with the Genomics Institute of the Novartis Research Foundation in order to develop multiple assays on its high-throughput microscopy platform, the company said Thursday.

The company and the institute will jointly develop a suite of applications for high-throughput cell-based screening, and develop for commercialization a set of assays, reagents, and software products.

Researchers at the Novartis facility will use the technology to improve their cellular genomics discovery program, said institute director Peter Schultz in a statement. The Genomics Institute, which is funded by the Novartis Research Foundation, focuses on applying functional genomics technologies to immunology, cancer, neuroscience, and virology.

Q3DM is a privately held San Diego, Calif., company that provides high-throughput microscopy platforms and optimized assays. Its core technologies include software and hardware for cellular image analysis, image data management, and fluorescence light source stabilization.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.